Key points
- Ukraine has received a humanitarian batch of the EPCLUSA drug for the treatment of children with viral hepatitis C worth over €700 thousand.
- 30 packages of the drug will provide treatment for 10 children under the age of 12.
- The drug will be distributed among specialized medical institutions in 7 regions of Ukraine.
- The assistance was provided thanks to the cooperation of the Office of the President, the Ministry of Health, the Center for Public Health, the Embassy of Ukraine to the Holy See, and the “Friends of the Sant’Egidio Community”.
The Ministry of Health of Ukraine received a humanitarian batch of the original EPCLUSA (sofosbuvir/velpatasvir) drug for the treatment of children aged 3 to 12 with viral hepatitis C.
The total value of the provided assistance is over €700 thousand. A total of 30 packages of the drug will be distributed – this will be enough to provide treatment for 10 children under the age of 12.
The drug will be distributed among specialized medical institutions in 7 regions of Ukraine according to the needs of patients.
The assistance was provided thanks to the cooperation of the Deputy Head of the Office of the President Iryna Vereshchuk, the Ministry of Health, the Center for Public Health of the Ministry of Health, the Embassy of Ukraine to the Holy See, and the public organization “Friends of the Sant’Egidio Community”.
Currently, in the world, for the treatment of viral hepatitis C in children under 12, there are only original medicines. Due to this, therapy remains expensive and limited.
In August 2025, the “Friends of the Sant’Egidio Community” organization had already transferred drugs for the treatment of viral hepatitis C – sofosbuvir/velpatasvir and sofosbuvir/ledipasvir – worth almost ₴59 million.
Viral hepatitis C is caused by a virus that is transmitted mainly through blood and primarily affects the liver.
In children, the infection is most often transmitted from mother to child during pregnancy or childbirth, as well as during medical interventions related to blood contact. Timely therapy helps prevent severe complications, including cirrhosis and liver cancer.
Read also:
Ukrainian doctors complete neuro-urology training to help patients with spinal cord injuries
